Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.063 AUD 0.00(0%)
Last update at 2026-11-06T04:12:00Z
VOLUME
508
Market Cap
4.60M

Momentum Score

…

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia and New Zealand. It offers topical anti-inflammatory creams, sprays, and roll-ons for the relief of joint and muscle pain under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. The company is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities, as well as sales and distribution activities. It exports its products to the United Kingdom and the United Arab Emirates. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.06
Low
0.06
High
52 Week Price Range
0.04
Low
0.18
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Wellnex Life Ltd is an Australian-listed company (WNX.AX) for which publicly available detail about core operations is limited. Because disclosures are scarce, growth drivers and competitive position are unclear; if the business operates in consumer health, potential attractions may include exposure to ageing populations and rising health spending, but these links are unverified.
Principal risks include limited public disclosure, execution and financing constraints typical of small listed companies, and regulatory or product-safety exposure if the company is active in health-related products.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.06
Dividend Yield
-
Revenue TTM
24.84M
Revenue Per Share
0.79
Gross Profit TTM
7.17M
Debt / Equity
1.30
ROE
-48.65%
Net Debt
8.82M
ROCE
-32.39%
Diluted EPS TTM
-0.14

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -4.55M -15.60M -13.74M -13.85M -7.45M
Net income -4.55M -15.60M -13.74M -13.85M -7.45M
Selling general administrative - 2.56M 7.86M 7.14M 8.58M
Selling and marketing expenses - 2.74M 2.89M 4.43M 1.67M
Gross profit 2.78M 6.88M -0.78M 4.74M 4.50M
Reconciled depreciation - - 0.77M 0.27M 0.12M
Ebit -2.43M -8.00M -11.34M -7.10M -5.68M
Ebitda -0.81M -6.62M -10.57M -6.82M -5.56M
Depreciation and amortization 1.62M 1.38M 0.77M 0.27M 0.12M
Operating income -2.43M -6.62M -7.51M -7.10M -5.68M
Other operating expenses 27.27M 30.25M 24.44M 34.99M 24.48M
Interest expense 1.54M 2.63M 2.40M 1.68M 0.96M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - 2.69M 1.73M 1.68M 0.96M
Net interest income - - -2.40M -1.68M -0.96M
Income tax expense - - -0.77M 1.70M 1.14M
Total revenue 24.84M 23.62M 16.93M 27.88M 18.61M
Total operating expenses 5.22M 13.50M 6.73M 11.85M 10.37M
Cost of revenue 22.05M 16.75M 17.71M 23.14M 14.11M
Total other income expense net -2.12M -8.98M -6.23M -5.05M -0.62M
Net income from continuing ops - - -13.74M -13.85M -7.45M
Net income applicable to common shares - -15.60M -13.74M -13.85M -7.45M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 23.78M 27.84M 31.48M 15.04M 19.61M
Intangible assets 0.04M 19.72M - 2.47M 0.46M
Other current assets 20.04M 1.54M 0.98M 2.47M 0.17M
Total liab 16.33M 16.59M 24.30M 14.45M 15.25M
Total stockholder equity 7.45M 11.25M 7.18M 0.59M 4.36M
Deferred long term liab - - - 0.52M -
Other current liab 1.11M 0.83M 0.46M 1.04M 1.63M
Common stock 152.11M 151.45M 131.08M 112.42M 102.62M
Capital stock - - - 112.42M 102.62M
Retained earnings -144.66M -140.97M -127.45M -115.56M -101.71M
Other liab - - - 0.10M 0.06M
Good will - - - 0.99M 5.00M
Other assets - - - 0.52M -
Cash 0.86M 0.50M 0.90M 0.32M 3.18M
Cash and equivalents - - - 0.32M 3.18M
Total current liabilities 16.27M 16.48M 24.21M 14.30M 9.80M
Current deferred revenue 0.21M - 5.65M - -
Net debt 8.82M 4.95M 9.76M 6.63M 4.68M
Short term debt 9.68M 5.45M 10.67M 6.90M 2.47M
Short long term debt - - - 6.79M 2.38M
Short long term debt total 9.68M 5.45M 10.67M 6.95M 7.86M
Other stockholder equity - - - 3.73M 3.45M
Property plant equipment - - - 0.20M 0.31M
Total current assets 23.75M 8.11M 10.45M 11.38M 13.84M
Net tangible assets - - - -2.35M -1.10M
Net receivables 2.48M 2.59M 4.38M 4.60M 6.17M
Long term debt - - - 0.00M 5.20M
Inventory 0.37M 3.48M 4.19M 3.03M 4.32M
Accounts payable 5.27M 10.20M 7.44M 6.35M 5.71M
Accumulated other comprehensive income 0.00M 0.78M 3.55M 3.73M 3.45M
Non currrent assets other - - 20.95M - -
Non current assets total 0.04M 19.73M 21.03M 3.66M 5.77M
Capital lease obligations - - - 0.16M 0.28M
Long term debt total - - - 0.05M 5.39M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - - -13.42M -2.20M -0.00M
Change to liabilities - - - 0.00M 5.82M
Total cashflows from investing activities 0.01M -8.29M -13.42M -2.20M -3.65M
Net borrowings - - 3.58M -1.93M 6.23M
Total cash from financing activities 3.17M 8.55M 20.82M 5.53M 7.66M
Change to operating activities - - - - 0.53M
Net income -4.55M -15.60M -13.74M -13.85M -7.45M
Change in cash 0.36M -0.41M 0.58M -2.86M -4.59M
Begin period cash flow 0.50M 0.90M 0.32M 3.18M 7.78M
End period cash flow 0.86M 0.50M 0.90M 0.32M 3.18M
Total cash from operating activities -2.81M -0.67M -6.82M -6.19M -8.61M
Issuance of capital stock - - 20.15M 8.17M 2.18M
Depreciation 1.62M 1.38M 0.82M 0.27M 0.15M
Other cashflows from investing activities 0.01M -8.29M -0.12M -2.20M 0.67M
Dividends paid - - - 10.45M 9.70M
Change to inventory 3.36M - -1.57M 1.29M -3.65M
Change to account receivables -2.67M - -0.25M 1.57M -5.29M
Sale purchase of stock - 15.90M -2.80M -0.71M -0.17M
Other cashflows from financing activities -1.14M 8.55M -0.11M 20.77M 18.73M
Change to netincome - - - 7.38M 1.28M
Capital expenditures 0.00M 0.00M 6.82M 0.00M 0.04M
Change in working capital -1.44M 0.00M 1.37M 2.06M -2.59M
Stock based compensation - 4.19M 0.49M 0.28M 0.63M
Other non cash items 1.57M 9.37M 4.24M 2.84M 4.69M
Free cash flow -2.81M -0.67M -6.82M -6.19M -8.65M

Peer Comparison*

Sector: Consumer Defensive Industry: Packaged Foods

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
WNX
Wellnex Life Ltd
-
-%
0.06 - 43.48 0.19 0.65 0.55 -4.76
A2M
The a2 Milk Company Ltd
-0.13
1.79%
7.13 29.04 28.74 2.68 5.94 2.85 17.82
BGA
Bega Cheese Ltd
0.02
0.31%
6.43 35.61 22.94 0.52 1.93 0.60 11.82
CBO
Cobram Estate Olives Ltd
-
-%
2.70 - - 4.79 2.48 6.63 185.44
RIC
Ridley Corporation Ltd
-
-%
2.68 38.29 13.42 0.35 2.01 0.53 4.50

Profile*

Wellnex Life Ltd

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia and New Zealand. It offers topical anti-inflammatory creams, sprays, and roll-ons for the relief of joint and muscle pain under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. The company is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities, as well as sales and distribution activities. It exports its products to the United Kingdom and the United Arab Emirates. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.

Port Park - Building 2, Port Melbourne, VIC, Australia, 3207

61 3 8399 9419

Name Title Year Born
Mr. George Karafotias B.Com. CEO, CFO & Exec. Director NA
Mr. Zlatko Bozinovski Chief Strategy Officer & Exec. Director NA
Mr. Zheng Li Company Sec. & Independent Non-Exec. Director NA
Ms. Angela Coppola Fin. & Admin. Exec. NA
Mr. George Karafotias B.Com. CEO, CFO & Executive Director NA
Mr. Zlatko Bozinovski Chief Strategy Officer & Executive Director NA
Mr. Zheng Li Company Secretary NA
Ms. Angela Coppola Finance & Administration Executive NA
Mr. George Karafotias B.Com. CEO, CFO & Executive Director NA
Mr. Zlatko Bozinovski Chief Strategy Officer & Executive Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…